Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 01, 2015 10:47 PM ET

Biotechnology

Company Overview of Tobira Therapeutics, Inc.

Key Executives for Tobira Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Laurent Fischer M.D.68 RelationshipsChief Executive Officer and Director51
Eckard Weber M.D.77 RelationshipsFounder, Director and Member of Nominating & Governance Committee65
Christopher Peetz No RelationshipsChief Financial Officer and Head of Corporate Development36
Helen Jenkins MANo RelationshipsChief Operating Officer51
Eric A. Lefebvre M.D.No RelationshipsChief Medical Officer51

Tobira Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Dennis G. Podlesak MBA 30 RelationshipsCalixa Therapeutics, Inc.57
Laurent Fischer M.D. 68 RelationshipsTobira Therapeutics, Inc.51
Eckard Weber M.D. 77 RelationshipsOcera Therapeutics, Inc.65
Jeffrey H. Cooper CPA 8 RelationshipsTobira Therapeutics, Inc.59
Pierre Legault CA, MBA, CPA 23 RelationshipsNephroGenex, Inc.54
View All Board Members

Tobira Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CA, MBA, CPAPierre Legault23 Relationships3 Executives
Compensation Committee Andrew J. Fromkin22 Relationships3 Executives
Nominating Committee CPAJeffrey H. Cooper8 Relationships3 Executives
Corporate Governance Committee CPAJeffrey H. Cooper8 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
356.3K
Bonus
209.5K
Total Short Term Compensation
437.0K
Total Value of Options
30.2M
Compensation as of Fiscal Year
Tobira Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Michael C Feenan Joins SCA as Vice President of Personal Care Business in North America
August 26, 2015 10:30 AM ET
Alissa Sears to Join Aunt Fannie's, Inc.'s Board of Advisors
August 24, 2015 1:22 PM ET
The National Detergent Co. SAOG Announces Board Changes
August 20, 2015 10:16 AM ET
Kimberly-Clark Corporation Announces Resignation of Linda Johnson Rice from the Board of Directors
August 18, 2015 8:42 PM ET
Aunt Fannie's, Inc. Appoints Jeff Grogg to its Board of Advisors
August 18, 2015 1:22 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tobira Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.